English (UK)
中文版chuhan zong
A mainland based family fund， heavily investing healthcare and biotechs
Wu Capital
associateFangyue Zou
Founded in Wuxi, 2017
Focus on development, manufacturing and marketing of drugs
Registered capital is RMB 280M
Consists of Wuxi Fortune, Qingzhipin Pharma and Sihuan Pharma
Annual revenues - RMB 1 billion (~0.5 billion for antibiotics)
To be public company within 5 years in China
Focus on development, manufacturing and marketing of drugs
Registered capital is RMB 280M
Consists of Wuxi Fortune, Qingzhipin Pharma and Sihuan Pharma
Annual revenues - RMB 1 billion (~0.5 billion for antibiotics)
To be public company within 5 years in China
BRIMED PHARMA GROUP
Planning Specialist
顺军 丁
西安联创生物医药孵化器有限公司（以下简称孵化器）是由西安市科技局和国家级西安高新区创业服务中心共同设立,2005年被国家科技部认定为国家级专业孵化器。孵化器依托西安地区的资源优势,为中药、天然药物、生物技术药物与各类医药中间体及原料药物的项目提供产品研发、中试、成果转化、投融资等方面的专业化服务。孵化器通过采取政府引导、依托企业、多元化投资的方式,聚合生物医药科研院所和企业的资源,初步形成了生物医药自主创新,相关资源聚集的效应。
西安联创生物医药孵化器有限公司
项目主管魏 丽冬
Chengdu Kanghong Pharmaceutical Co., Ltd. is a pharmaceutical company integrating R & D and production. Kanghong has involved in the fields of traditional Chinese medicine, chemical medicine, biological medicine and medical devices. One of the products- conbercept, first in class has been developing in more than 30 countries in the world.
Chengdu Kanghong Pharmaceutical Co., Ltd
立项调研部 主任佳 付
J Rich Capital Inc. is an investment banking boutique with offices in Shanghai and Silicon Valley. Established in 2008, we specialize in mergers and acquisitions, capital raising, and asset management services within biotech, pharmaceutical, and real estate industries. Our expansive capital management capabilities as well as our deep understanding of the China market differentiate us from our peers in the financial industry.
Responsive Web Design powered by 